RHY 0.00% 11.5¢ rhythm biosciences limited

Ann: MST Access Financial Diagnostics Presentation, page-51

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5 Posts.
    & @clio

    Of course! Implementation and integration are incredibly important, I like what you guys are saying.

    @borano

    You raise a great point, and I've seen those analyst reports. I'm not claiming to be an expert on the matter by any means, but from my understanding, please correct me if you disagree but is the argument you're trying to put forward that this is actually a more saturated failing market than some might assume? I've looked into some of the companies that you've shared and you seem to get a lot of people in here thinking even if they don't agree with you. I also see some of the counter-arguments people have shared about your posts which have also been pretty compelling as it's very difficult to try and compare all these companies' strategies. Beyond trying to compare apples with apples or oranges with pears do you think that there is just something fundamentally wrong with the idea of blood test kits for colon cancer or are u long other technology that you just think is better? What are your thoughts on what Government bodies such as NCSR would think are the limitations to adding this sort of thing to their programs? Because you are right, 100,000 units @ $50 a piece is not going to make us all rich, but what would make me happy and turn this technology into a long-term play is some sort of government recognition and standardization like the current FIT test. From what I've been able to gather it seems that at least some of the other companies you've spoken about can produce great results but to me, their roadmaps seem to be behind Rhythm? Is there currently a TGA-approved cheap test kit just like ColoSTAT on the market that the government is just choosing to ignore? Or are none of these companies at the stages of development that could potentially provide this service tomorrow reliably and cheaper than FIT? This seems to me to be the race that they are in. So yes I understand that there are better results out there, but who is going to get to the market first and replace the current test system that I think we can all agree is pretty CRAP?
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
11.5¢
Change
0.000(0.00%)
Mkt cap ! $28.58M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 5969 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 21297 1
View Market Depth
Last trade - 16.16pm 15/11/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.